ArticleHaematologica2023

Heterogeneity in long-term outcomes for patients with Revised International Staging System stage II, newly diagnosed multiple myeloma.

Anais Schavgoulidze et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.